EXCLUSIVE: Pfizer to stop selling Premarin hormone therapy in Canada Reuters
EXCLUSIVE: Pfizer to stop selling Premarin hormone therapy in Canada - Reuters
In short
Pfizer will stop selling its hormone therapy drug Premarin across Canada. The decision will affect the regional supply of the established therapy option. Patients and healthcare providers using the drug will need to transition to alternative available medical treatments.
Key points
- Patients in Canada will no longer be able to access Pfizer's Premarin hormone therapy.: Patients in Canada will no longer be able to access Pfizer's Premarin hormone therapy.
- The drug manufacturer is ending the commercial availability of this specific regional med…: The drug manufacturer is ending the commercial availability of this specific regional medication.
- Alternative treatment plans will be necessary for individuals currently utilizing this ho…: Alternative treatment plans will be necessary for individuals currently utilizing this hormone therapy.